Med-Tech Launcher Program 2026: TRL 7-9 Accelerator for Medical Devices

The Med-Tech Launcher Program is a late-stage accelerator run by the UP Promote Pharma Council (UPPPC), a Section 8 company set up by the Government of Uttar Pradesh through its Department of Medical Education. It works with medical devices and In-Vitro Diagnostics that have already cleared the prototype hurdle and now need help reaching the market.

The programme exists because of a familiar gap in Indian MedTech: support is abundant up to the prototype stage and then thins out fast. Moving from a validated prototype to clinical validation, regulatory clearance, manufacturing at scale and commercial launch — the stretch often called the Valley of Death — is where a great many promising devices stall. UPPPC has built this initiative specifically around technologies at Technology Readiness Levels 7 to 9, where those demands become decisive.

Instead of cash, the accelerator supplies the institutional machinery late-stage MedTech teams usually find hard to reach: multi-centric clinical validation, ethically compliant clinical datasets, expert regulatory guidance, help with certifications, specialised mentorship and structured commercialisation support. The wider aim is to bring academia, industry and clinicians onto the same platform — generating intellectual property and supporting economic growth in Uttar Pradesh along the way.

• Late-stage MedTech accelerator for innovations at TRL 7-9
• Medical devices and In-Vitro Diagnostics with a validated prototype
• Clinical trials, testing and usability studies at 11 premier medical institutions in Uttar Pradesh
• Hands-on CDSCO, QMS, GMP, ISO 13485 and ISO 14155 support
• No upfront cost and no cash grant — success-linked revenue share after commercial launch
• Investor demo days and introductions to VCs, industry partners, BIRAC and Startup India Seed Fund Scheme

Eligibility turns on technological maturity, so the first filter is your TRL. Innovations must sit between TRL 7 and TRL 9 — a prototype proven in an operational environment at the lower end, a fully qualified and demonstrated system at the upper end.

• Product type: only medical devices and In-Vitro Diagnostics qualify. That covers diagnostics, therapeutic devices, surgical instruments, implants, monitoring systems and digital health solutions classified as medical devices, along with reagents and instruments.
• Validation status: a functional prototype must already exist, backed by technical and preliminary clinical data — lab testing, pre-clinical work or early human pilot data — demonstrating feasibility, early safety signals and a clear link to an identified unmet need.
• Team: a dedicated, multi-disciplinary core team is preferred, with demonstrated expertise in medical science, engineering, regulatory affairs and business development for MedTech.
• Market and regulatory readiness: you must articulate a defined target market tied to a significant unmet clinical need, and show a preliminary grasp of the route to market approval in India through CDSCO.
• Intellectual property: applicants need ownership of, or a licence to, core IP such as patents or trademarks — or a credible strategy for building defensible IP and assessing freedom to operate (FTO).

Med-Tech Launcher Program 2026: TRL 7-9 Accelerator for Medical Devices is open to startups at any stage. It is open to startups registered anywhere in India.

Applications for Med-Tech Launcher Program 2026: TRL 7-9 Accelerator for Medical Devices are open and the current deadline is 15 Oct 2026. Applications are closing soon, so prepare your documents early. Deadlines can change — always reconfirm on the official source before submitting.

Worth saying first: this is not a cash-grant programme. UPPPC does not disburse upfront money to participants. What it offers is in-kind, non-financial support along the commercialisation journey, provided at zero upfront cost.

Clinical validation and refinement (TRL 7-8 focus)

• Facilitation of ethics and regulatory approvals
• Direct institutional access to 11 premier medical institutions in Uttar Pradesh for clinical trials, product testing, usability studies and expert feedback
• Secure, controlled access to de-identified clinical datasets
• Clinical mentorship to support iterative product refinement

Regulatory preparedness and quality assurance (TRL 8-9 focus)

• A dedicated regulatory team working hands-on with CDSCO pathways, medical device classification, compliance and documentation
• Specialised QMS and GMP workshops, plus one-on-one sessions on standards such as ISO 13485 and ISO 14155
• Access to certified quality management consultants and legal advisory support

Market access and commercialisation (TRL 9 focus)

• Intensive business development training covering market analysis, pricing and IP protection
• Support in sharpening your value proposition and investor pitch
• Funding facilitation through curated introductions to late-stage venture capitalists, strategic industry partners and government grant agencies such as BIRAC and the Startup India Seed Fund Scheme, via organised investor demo days and networking

What participation costs There is nothing to pay upfront. In its place, a success-linked revenue-sharing mechanism applies once the product is commercially launched — aligned with state innovation objectives:

• Participating academic and research institutions may receive up to 10% of post-tax Gross Annual Revenue (GAR) from product sales, for a maximum of ten years
• UP Promote Pharma Council receives up to 5% of post-tax GAR
• Collaborating institutions and contributors may receive royalties of up to 20% from IP monetisation, based on documented contributions

Med-Tech Launcher Program 2026: TRL 7-9 Accelerator for Medical Devices is offered by UP Promote Pharma Council (UPPPC), a government body. As a government-backed grant, it is publicly funded and open to eligible startups across India. You can verify current details and timelines on the provider's official website before applying.

1. Online application and initial screening Applications go in through the portal at https://uppromotepharmacouncil.org/medtech-launcher. You will need detailed technical specifications of the innovation, your existing validation data, profiles of the core team, a clear statement of the market opportunity and a proposed regulatory strategy. The Program Management Unit (PMU) then screens submissions against the basic eligibility criteria, including the TRL band and product focus.

2. Detailed review and shortlisting Eligible applications go to a multi-disciplinary panel made up of MedTech specialists, clinicians from the identified institutions, regulatory affairs experts and business development professionals. Each is scored on clinical impact, technical maturity, market potential, regulatory feasibility, IP strength and team capabilities. Only high-potential innovations are shortlisted.

3. Interviews and due diligence Shortlisted teams are invited for in-depth interviews with the Apex Screening Board, chaired by the Managing Director of UP Promote Pharma Council, with representation from the Department of FSDA, NIPER Raebareli, CSIR-CDRI, NIB, IITs, and subject matter experts from the identified medical institutions and industry associations. Expect detailed technical and commercial discussion, an assessment of team dynamics and commitment, and verification of the claims made in your application. Clinical experts also weigh how readily the innovation can be integrated into real-world care settings.

4. Final selection Cumulative scores from the review and interview stages, along with panel consensus, decide the outcome. Priority goes to solutions with a clear pathway to addressing unmet clinical needs in Uttar Pradesh and a high probability of clearing clinical validation, regulatory approval and commercialisation.

Before you apply to Med-Tech Launcher Program 2026: TRL 7-9 Accelerator for Medical Devices, keep the following documents ready:

• A pitch deck or short business plan describing the problem, product and traction
• Company registration documents and PAN
• Founder identification (PAN / Aadhaar) and brief profiles
• Recent financial statements or projections
• Product details — a demo, prototype or working link if available

Exact requirements are confirmed on the official application portal — treat this as a preparation checklist.